Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

HealthQuest Capital

Founders Garheng Kong

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 46
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 29
Rounds per year 4.18
Lead investments 16
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.37
Exits 9
Key employees 5
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Medical Device
  • Health Diagnostics
  • Medical
  • Biotechnology
Summary

The venture was found in North America in United States. The main department of described VC is located in the Menlo Park.

The high activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this HealthQuest Capital performs on 15 percentage points less the average number of lead investments. Considering the real fund results, this VC is 34 percentage points more often commits exit comparing to other organizations.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the HealthQuest Capital, startups are often financed by Sofinnova Investments, BioStar Ventures, Aisling Capital. The meaningful sponsors for the fund in investment in the same round are Aisling Capital, Safeguard Scientifics, Polaris Partners. In the next rounds fund is usually obtained by Silicon Valley Bank, Smith & Nephew, Safeguard Scientifics.

Besides them, we counted 5 critical employees of this fund in our database.

The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Health Care. Among the various public portfolio startups of the fund, we may underline Ajax Health, Magnolia Medical Technologies, Trice Medical

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of HealthQuest Capital:
Typical Co-investors
HealthQuest Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after HealthQuest Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aurora Private Equity Aberdeen, Scotland, United Kingdom
ChimeraBio Dundee, Dundee City, United Kingdom
China Resources China, Hong Kong, Hong Kong Island
Equus Total Return,Inc. Houston, Texas, United States
Frontier Growth Charlotte, North Carolina, United States
Fujikura Japan, Koto
Future Planet Capital England, London, United Kingdom
Hexcel Corporation Connecticut, Stamford, United States
KOEI TECMO HOLDINGS Japan, Kanagawa Prefecture, Yokohama
Lingshi Touzi China, Guangdong, Shenzhen
Manipal Hospitals Bangalore, India, Karnataka
ProQuest Ann Arbor, Michigan, United States
RockBridge Capital Partners Columbus, Ohio, United States
Serve Credit Union Des Moines, Iowa, United States
STC Ventures Dubai, United Arab Emirates
SulzerMedica USA -
Telecom Infra Project California, Menlo Park, United States
The Jagen Group Australia, Melbourne, Victoria
The Singer Group Maryland, Reisterstown, United States
WRV Capital California, Menlo Park, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Inbound Health

$30M20 Sep 2023 Minneapolis, Minnesota, United States

Perspectum

Health Care
Medical
Medical Device
Wellness
$42M05 Jan 2023 Oxford, England, United Kingdom

Thirty Madison

Health Care
Personal Health
Pharmaceutical
Wellness
$140M02 Jun 2021 New York, New York, United States

Perspectum

Health Care
Medical
Medical Device
Wellness
$35M14 Apr 2020 Oxford, England, United Kingdom

Ajax Health

Clinical Trials
Health Care
Medical Device
$15M18 Jun 2019 California, United States

Bardy Diagnostics

Health Care
Health Diagnostics
Medical
Medical Device
$35M16 Apr 2019 Seattle, Washington, United States

Ajax Health

Clinical Trials
Health Care
Medical Device
$85M14 Apr 2019 California, United States

Magnolia Medical Technologies

Health Care
Health Diagnostics
Medical Device
$20M30 Jan 2019 Seattle, Washington, United States

Trice Medical

Health Care
Health Diagnostics
Medical
Medical Device
$18M14 Jan 2019 Pennsylvania, United States
News
Thirty Madison Raises $140M in Series C Funding

– Thirty Madison, a New York-based healthcare company that focuses on people with chronic conditions, raised $140M in Series C funding.
– The round was led by new investor HealthQuest Capital with participation from Mousse Partners and Bracket Capital and existing investors Polaris Partners, Johnson & Johnson Innovation – JJDC, Inc., Northzone, Greycroft, and others.
– The company intends to use the funds to expand access to its care model for people who suffer from chronic conditions and enhance the capabilities of its proprietary platform.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent HealthQuest Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 46
Average round size 34M
Rounds per year 4.18
Peak activity year 2019
Lead investments 16
Follow on index 0.37
Exits 9
Group Appearance index 0.87

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Inbound Health

$30M20 Sep 2023 Minneapolis, Minnesota, United States

Perspectum

Health Care
Medical
Medical Device
Wellness
$42M05 Jan 2023 Oxford, England, United Kingdom

Thirty Madison

Health Care
Personal Health
Pharmaceutical
Wellness
$140M02 Jun 2021 New York, New York, United States

Perspectum

Health Care
Medical
Medical Device
Wellness
$35M14 Apr 2020 Oxford, England, United Kingdom

Ajax Health

Clinical Trials
Health Care
Medical Device
$15M18 Jun 2019 California, United States

Bardy Diagnostics

Health Care
Health Diagnostics
Medical
Medical Device
$35M16 Apr 2019 Seattle, Washington, United States

Ajax Health

Clinical Trials
Health Care
Medical Device
$85M14 Apr 2019 California, United States

Magnolia Medical Technologies

Health Care
Health Diagnostics
Medical Device
$20M30 Jan 2019 Seattle, Washington, United States

Trice Medical

Health Care
Health Diagnostics
Medical
Medical Device
$18M14 Jan 2019 Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: